The two techniques in question are both built on diffusion-weighted imaging, or DWI, a cornerstone of modern oncological MRI. DWI works by sensitizing the MRI signal to the random Brownian motion of water molecules. In dense, cellular tumors, water molecules bump into cell membranes and extracellular matrix far more often than they do in loose, healthy tissue, so water diffusion is restricted and the tumor lights up brightly on DWI images. From these images radiologists calculate a quantity called the apparent diffusion coefficient, or ADC, which quantifies diffusion numerically. Lower ADC values generally correspond to more cellular, more aggressive tissue, and ADC thresholds are widely used to help distinguish malignant from benign lesions, to assess treatment response, and to characterize tumors across the body.

Conventional DWI, which the researchers call General-DWI, uses a well-established acquisition method known as single-shot echo-planar imaging combined with parallel imaging. It covers the entire field of view in one rapid sweep, which makes it fast and robust, but it comes with an inherent trade-off: the large field of view and the physics of echo-planar readouts introduce geometric distortion, blurring, and image noise, particularly in the abdomen, where breathing motion and nearby air-filled organs degrade image quality. For gastric cancer specifically, where lesions can be small and sit amid a tangle of motion-prone anatomy, those artifacts can blur the very margins clinicians most need to see.

Enter Zoom-DWI, short for zonally oblique multi-slice diffusion-weighted imaging. Instead of exciting the whole imaging volume and then reconstructing the slice of interest, Zoom-DWI uses a targeted, two-dimensional radiofrequency excitation scheme that excites only a thin, obliquely oriented slab containing the anatomy of interest. By never exciting tissue outside that zone in the first place, the technique avoids the aliasing and fold-over artifacts that conventional acquisitions must otherwise suppress with parallel imaging acceleration. The theoretical payoff is a smaller effective field of view, reduced distortion, and crisper anatomical detail, all without requiring the patient to hold their breath, since the sequence is acquired during free breathing. The technique has shown promise in other organs, including prostate and breast imaging, but its behavior in gastric cancer had not been systematically benchmarked against conventional DWI until now.

The research team, led by radiologists at Daping Hospital of Army Medical University in Chongqing, conducted a single-center retrospective study of 70 patients with histopathologically confirmed gastric cancer who underwent abdominal MRI between March 2023 and October 2024. Each patient received both sequences: the conventional free-breathing, fat-suppressed General-DWI and the targeted Zoom-DWI. The investigators then evaluated the two techniques on three fronts. First, they scored image quality qualitatively on a five-point scale, with two independent readers assessing features such as tumor boundary delineation and image noise. Second, they measured mean ADC values within carefully drawn tumor regions of interest. Third, they computed entropy metrics, a texture-analysis measure that captures the heterogeneity, or spatial irregularity, of the signal within the tumor, which some researchers hope can serve as an imaging proxy for tumor aggressiveness.

The headline finding on image quality was a genuine split decision. Zoom-DWI scored significantly higher for tumor boundary delineation, with a mean score of 3.78 compared with lower scores for the conventional technique, a difference that was highly statistically significant. In plain terms, radiologists could see where the tumor ended and healthy tissue began more clearly with the zoomed approach, which matters enormously for staging, treatment planning, and targeting biopsies. But the sharper view came at a cost: Zoom-DWI performed significantly worse on image noise, scoring 3.76 on the noise assessment, indicating that the targeted excitation approach produces grainier, less clean images than the conventional method. This trade-off between spatial clarity and noise is a familiar refrain in MRI physics, but quantifying it in gastric cancer provides practical guidance for radiologists deciding which sequence to deploy.

The quantitative results revealed something more consequential. General-DWI produced significantly higher ADC values than Zoom-DWI: 1.43 versus 1.33 in the standard units of ten-thousandths of a square millimeter per second, a difference that was highly significant. To dig deeper, the team applied linear mixed-effects modeling, a statistical framework that can separate true sequence effects from patient-to-patient variability. The modeling revealed a systematic ADC underestimation bias of 0.096 associated with Zoom-DWI, meaning the zoomed technique consistently reads diffusion as slightly more restricted than the conventional method does in the same tumor. This is not random scatter; it is a predictable, directional shift baked into the physics of the acquisition.

Why does this matter so much? Because ADC values are not just descriptive numbers, they are diagnostic instruments. Radiologists and researchers have accumulated years of threshold-based criteria, for example cutoffs used to separate malignant from benign tissue or to grade treatment response, all calibrated against conventional DWI acquisitions. If a department switches to Zoom-DWI and plugs its measurements into those established thresholds, the systematic bias could push borderline lesions across diagnostic cutoffs and change clinical decisions. The correlation between the two techniques was extremely strong for ADC, with a Pearson correlation coefficient of 0.906, and strong for entropy at 0.776, meaning the two methods track each other well in relative terms. But correlation is not agreement. Bland-Altman analysis, the standard statistical tool for assessing whether two measurement methods can be used interchangeably, revealed consistent systematic ADC deviation between the sequences and wide variation in entropy measurements. The authors’ conclusion is unambiguous: the two sequences cannot share unified quantitative diagnostic cutoffs.

Entropy, interestingly, emerged as the more forgiving metric. Mean entropy values were statistically indistinguishable between the two sequences, at 4.70 for Zoom-DWI and 4.72 for General-DWI, a difference with no statistical significance. This suggests that texture heterogeneity measurements may be more robust to the choice of acquisition technique than ADC values are, an encouraging sign for researchers pursuing radiomics approaches to gastric cancer characterization. However, the wide limits of agreement observed for entropy in the Bland-Altman analysis caution against assuming that individual patient measurements can be swapped freely between sequences, even if group-level means agree.

The study’s practical message for clinics is measured and clear. Zoom-DWI delivers superior visualization of tumor margins, which could improve staging accuracy and help clinicians delineate disease, but it carries higher image noise and produces systematically lower ADC values that are incompatible with existing diagnostic thresholds. The authors therefore recommend that Zoom-DWI serve only as a complementary sequence in gastric cancer MRI, deployed when crisp anatomical delineation is the priority, while conventional DWI remains the backbone for quantitative ADC-based assessments. For patients, the takeaway is that the sharper picture on the radiologist’s screen is real and valuable, but the numbers behind it must be interpreted in the context of the technique that produced them. As targeted diffusion imaging spreads through clinical practice, this study offers a timely reminder that in medical imaging, seeing better and measuring the same are two very different achievements, and that the transition between techniques demands recalibration, not just enthusiasm.

Subject of Research: Comparison of Zoom-DWI and conventional diffusion-weighted MRI for image quality, ADC values, and entropy in gastric cancer imaging

Article Title: Zoom-DWI versus general-DWI in gastric cancer: a comparative evaluation of image quality, apparent diffusion coefficient, and entropy

Article References: Xie, H., Wang, H., Cao, Z., Zhao, M., Chen, D., Guo, Y., Liu, J., Zhang, L., Wang, X., Ran, Q., & Wang, S. (2026). Zoom-DWI versus general-DWI in gastric cancer: a comparative evaluation of image quality, apparent diffusion coefficient, and entropy. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02766-6

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02766-6

Keywords: gastric cancer, diffusion-weighted imaging, Zoom-DWI, apparent diffusion coefficient, MRI, image quality, entropy, echo-planar imaging, radiology, tumor delineation, Bland-Altman analysis, cancer imaging

The technique, whose full name is Deep-learning Enabled Precise Imaging via multi-Contrast multi-shoT EPI for Accelerated head scan, was evaluated in a study published in BMC Medical Imaging. Rather than accelerating only a single imaging sequence, DEPICTA uses an echo-planar imaging, or EPI, framework combined with deep learning reconstruction to deliver multiple clinically important contrast weightings—T1-FLAIR, T2-weighted, T2-FLAIR, and diffusion-weighted imaging—within a single ultrafast session. EPI is one of the fastest acquisition strategies available to MRI physicists because it collects an entire two-dimensional image from a single excitation, but it has historically suffered from geometric distortion and blurring. The innovation of DEPICTA lies in pairing a multi-shot EPI readout with neural-network-based reconstruction that fills in the missing spatial and contrast information left by aggressive undersampling of the raw data.

The study enrolled 124 consecutive patients who presented with a clinical indication for brain MRI between August and September 2025. Each participant underwent both a conventional brain MRI protocol and the ultrafast DEPICTA examination, allowing the researchers to compare the two approaches head to head in the same individuals. The cohort had a mean age of 49 years with a standard deviation of 22, and comprised 64 men and 60 women—a spread of ages and indications that the investigators argue reflects the reality of a working radiology department rather than the idealized conditions of a laboratory study. Because the design was prospective, the DEPICTA acquisition was planned in advance rather than applied retrospectively to archived scans, which strengthens the claim that the results are achievable in routine clinical practice.

The headline result is deceptively simple: DEPICTA achieved a total acquisition time of 1 minute and 27 seconds for the multi-contrast brain examination. That figure places the entire scan comfortably within the 100-second threshold set by the study title and represents a dramatic compression relative to conventional protocols, which typically allocate several minutes to each individual contrast sequence. In the ultrafast framework, the multi-shot EPI readout gathers data from multiple contrasts in a coordinated fashion, and the deep learning reconstruction model, trained to recognize the relationship between undersampled and fully sampled data, synthesizes images that would otherwise be unattainable at such speed. The significance is not merely convenience. Shorter scans reduce motion artifacts, ease the burden on claustrophobic or uncooperative patients, and open the door to MRI for populations—such as critically ill patients in intensive care units, confused elderly patients, or restless children—for whom prolonged examinations have been impractical or impossible.

Of course, speed alone is worthless if the images cannot be trusted, so the investigators subjected the ultrafast scans to rigorous qualitative and quantitative scrutiny. Two neuroradiologists independently scored overall image quality, gray-white matter differentiation, and the presence of artifacts, without knowledge of each other’s assessments. Their verdicts were nuanced. On overall image quality and gray-white matter differentiation, the ultrafast scans scored lower than conventional MRI—an expected consequence of aggressive acceleration—but remained in the range the study characterized as sufficient for clinical use. In other words, the deep learning reconstructions traded a measure of fine tissue contrast for a massive gain in acquisition speed, yet the images still delivered the diagnostic fundamentals that radiologists need.

Notably, on two crucial dimensions the ultrafast technique actually outperformed the conventional protocol. DEPICTA images showed fewer artifacts and higher signal-to-noise ratio on both T1-FLAIR and diffusion-weighted imaging compared with their conventional counterparts, differences that reached statistical significance at P < 0.05. This finding is arguably the most surprising of the study. Diffusion-weighted imaging, which is indispensable for detecting acute stroke, is exquisitely sensitive to motion, and the conventional acquisition of DWI is a frequent casualty of patient movement. By collapsing the acquisition window to seconds and using learned reconstruction to suppress noise, the ultrafast approach produced cleaner, sharper diffusion images precisely where conventional MRI is most fragile. Higher signal-to-noise ratio means the deep learning reconstruction is not merely hallucinating plausible anatomy; it is consolidating genuine signal into images that rival, and in some respects exceed, those built from far more data.

Beyond radiologists’ subjective impressions, the team examined whether measurements taken from ultrafast images could be trusted as surrogate quantities for clinical decision-making. They measured lesion sizes, apparent diffusion coefficient values within lesions—a quantitative marker of water diffusion used to characterize stroke and tumors—and the widths of the lateral, third, and fourth ventricles, which serve as indirect indicators of intracranial pressure and hydrocephalus. The ultrafast measurements agreed well with those from conventional MRI for lesion size, lesion ADC, and the width of the lateral and third ventricles, demonstrating the quantitative comparability that regulators and clinicians would require before adopting such a technique for serial monitoring. The one exception was the width of the fourth ventricle, where the two methods diverged significantly, with a P value of 0.006. The authors note this single discordance as an honest limitation, likely attributable to the small size of the fourth ventricle and the resolution constraints of the accelerated acquisition in that region.

The study also included a T2*-weighted and susceptibility-weighted module in the DEPICTA protocol, which offers the potential to detect microbleeds and venous abnormalities. However, the researchers explicitly excluded this module from their comparative image-quality and quantitative analyses, framing the full multi-contrast capability as promising but not yet validated at the level of the other sequences. That methodological restraint signals a careful, staged approach: the team is claiming feasibility for the validated contrasts while flagging the more exotic components of the protocol for future evaluation. It is a reminder that in medical imaging, enthusiasm must always be tempered by the discipline of head-to-head validation against the established standard.

The implications of the study extend well beyond Huashan Hospital. If a complete multi-contrast brain MRI can be delivered in under 90 seconds, the economics of neuroimaging begin to change. Scanner throughput could increase substantially, shortening waiting lists in overburdened health systems. Emergency departments could integrate near-instant brain MRI into acute stroke pathways, where every minute of delayed diagnosis translates into lost neurons. Patients in intensive care units, who currently must often be transported with ventilators and monitoring equipment into the magnet room for lengthy scans, could be imaged with less physiological risk. And populations historically excluded from MRI—patients with dementia who cannot follow instructions, young children who would otherwise require sedation—become plausible candidates for high-quality imaging because even brief cooperation is enough. The deep learning reconstruction also carries challenges of its own, since neural networks can introduce subtle biases and must be validated across diverse populations, scanner vendors, and disease spectra before widespread deployment.

The research was approved by the ethical board of Huashan Hospital, Fudan University, conducted with written informed consent, and adhered to the Declaration of Helsinki. It was supported by the National Natural Science Foundation of China under grant 82271966 and the Explorers Program of Shanghai under grant 24TS1410800. The corresponding authors are Yiping Lu and Bo Yin of the Department of Radiology at Huashan Hospital, and the study was a collaboration among co-first authors Mengdi Gao, Nan Mei, Jie Qin, Qirui Fu, and Xuanxuan Li, alongside Jing Du, Ke Sun, and Yiping Lu. Published open access, the work invites replication at other centers—a necessary step before an 87-second brain MRI moves from feasibility study to daily practice. For now, the message is clear: the era of the hundred-second brain scan is no longer hypothetical, and it has been delivered not by a bigger magnet but by an algorithm that knows what to do with less.

Subject of Research: Prospective feasibility of deep learning reconstructed ultrafast multi-contrast brain MRI completed within 100 seconds

Article Title: Ultrafast brain MRI within 100 s based on deep learning reconstruction: a prospective feasibility study

Article References: Gao, M., Mei, N., Qin, J., Fu, Q., Li, X., Du, J., Sun, K., Lu, Y., & Yin, B. (2026). Ultrafast brain MRI within 100 s based on deep learning reconstruction: a prospective feasibility study. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02778-2

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02778-2

Keywords: brain MRI, deep learning, ultrafast MRI, DEPICTA, echo-planar imaging, image reconstruction, BMC Medical Imaging, diffusion-weighted imaging, radiology, medical imaging, Huashan Hospital, MRI acceleration